BlackRock Health Sciences Term Trust Q1 2026 Commentary (NYSE:BMEZ)
· seekingalpha.com
Over the quarter, the BlackRock Health Sciences Term Trust increased its exposure to pharmaceuticals and biotechnology firms.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...